Fibromyalgia News

The FDA has granted fast track designation to a sublingual tablet form of the muscle relaxant cyclobenzaprine hydrochloride for the management of fibromyalgia, according to a press release from the manufacturer.

Rheumatoid arthritis and fibromyalgia are among the most common comorbidities identified in patients following a diagnosis of osteoarthritis, according to data presented at the EULAR 2024 Congress.

Among adults with arthritis, severe joint pain is significantly more prevalent in Black, Hispanic, American Indian and Alaska Native patients vs. white patients, according to data published in Arthritis Care & Research.

A blood sample analysis using Raman spectroscopy, combined with statistical modeling, was sufficient to diagnose fibromyalgia, according to data published in Biomedicines.

The common consensus for some time has been that the prevalence of autoimmunity and autoimmune diseases has been on the rise.

A recent NIH study of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome suggests that the condition is a “distinct entity,” with somatic and cognitive issues that are centrally mediated.

Changes in intestinal microbiota could play a part in the development of fibromyalgia, most feasibly along the gut-brain axis, according to a systematic review published in the International Journal of Rheumatic Diseases.

SCOTTSDALE, Ariz. — Long COVID, fibromyalgia and chronic fatigue syndrome demonstrate overlapping characteristics that warrant further investigation, according to a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.

SAN DIEGO — Patients with rheumatoid arthritis who reported having long COVID in the past year demonstrated “many symptoms” of long COVID prior to initial infection,” according to data presented at ACR Convergence 2023.